Due to global supply pressures on GLP-1 agonists the suppliers of both Trulicity and Victoza have advised Pharmac that supply constraints will continue through 2024.

Eli Lilly and Novo Nordisk, the suppliers of Trulicty and Victoza respectively have advised Pharmac they can only secure enough stock for people currently taking these medicines.

Shortages will be variable between pharmacies across the country. As of May 2024 Pharmac no longer recommends patients struggling to source these treatments to contact them directly.

Pharmac now recommends “If you are missing doses because of[sic] you can’t regularly access your medicine, we strongly advise you to discuss other treatment options with your prescriber”

We understand that supply issues with medicines can be frustrating. ZOOM Pharmacy will do everything that we can to secure supply but there will be supply shortages and that we are completely reliant on the supplier and Pharmac for supply information.

Learn more about these treatments:

Dulaglutide (Trulicity)

Liraglutide (Victoza)